Shares of Welltower WELL have gained 18.5% in the past six months, outperforming the industry's decline of 6%.

Welltower owns a well-diversified portfolio of healthcare real estate assets in the key markets of the United States, Canada and the U.K. Given an aging population and an expected rise in senior citizens’ healthcare expenditure, Welltower’s senior housing operating (SHO) segment is well-poised to benefit from this positive trend. The outpatient medical (OM) portfolio is expected to benefit from favorable outpatient visit trends in the near term.

Analysts seem positive on this healthcare REIT, currently carrying a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for its 2024 FFO per share has been revised a cent northward to $4.30 over the past week.

Image Source: Zacks Investment Research

Factors Behind the Surge in WELL Stock

The senior citizens’ population is expected to rise in the years ahead. As a result, the national healthcare expenditure by senior citizens, who constitute a major customer base of healthcare services and incur higher healthcare expenditures than the average population, is likely to increase in the upcoming period. Muted new supply has also been a tailwind for this industry. Capitalizing on these positive aspects, WELL’s SHO portfolio is well-prepared for compelling multiyear revenue growth. For 2024, management has anticipated the same-store SHO NOI to grow 22%-24%, from the previous guidance range of 19-23%, driven by favorable results.

Historically, there has been a favorable outpatient visit trend compared with in-patient admissions. Banking on this, the company is optimizing its OM portfolio, growing relationships with health system partners and deploying capital in strategic acquisitions. Given the favorable secular trends and growing need for value-based care, the company’s efforts to strengthen its OM footprint will boost long-term growth.

Welltower focuses on strategic portfolio optimization and synergistic collaborations with health systems to invest in the next-generation assets of health and wellness care delivery. The company has resorted to capital-recycling activities to finance near-term investment and development opportunities, paving the way for its long-term growth.

Welltower has a healthy balance sheet position and ample liquidity to meet near-term obligations and fund its development pipeline. As of Sept. 30, 2024, it had $8.8 billion of available liquidity, including $3.8 billion of cash & restricted cash and full capacity under its $5 billion line of credit. As of Sept. 30, 2024, the net debt to adjusted EBITDA was 3.73X. With higher organic cash flow, driven by the recovery in the SHO portfolio, this ratio is expected to improve in the upcoming quarters. Moreover, Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.9 years, thereby enhancing its financial flexibility.

Key Risks for WELL

A competitive landscape in the senior housing market and tenant concentration in its triple-net portfolio are likely to weigh on Welltower.

Other Stocks to Consider

Some other top-ranked stocks from the broader REIT sector are Cousins Properties CUZ and SL Green Realty SLG, each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

The Zacks Consensus Estimate for Cousins Properties’ 2024 FFO per share is pinned at $2.68, which suggests year-over-year growth of 2.3%.

The Zacks Consensus Estimate for SL Green’s 2024 FFO per share stands at $7.78, which indicates an increase of 57.5% from the year-ago period.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cousins Properties Incorporated (CUZ) : Free Stock Analysis Report

SL Green Realty Corporation (SLG) : Free Stock Analysis Report

Welltower Inc. (WELL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research